12:00 AM
Nov 25, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

iPierian preclinical data

In a mouse model of tauopathy, a mouse formulation of IPN007 for 6 months inhibited global disease progression and led to improvements...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >